Phase 1 Cohort Expansion of Flotetuzumab, a CD123xCD3 Bispecific Dart (R) Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Uy, GL; Rettig, MP; Vey, N; Godwin, J; Foster, MC; Rizzieri, DA; Arellano, ML; Topp, MS; Huls, G; Jongen-Lavrencic, M; Martinelli, G; Paolini, S; Ciceri, F; Carrabba, MG; Sweet, KL; Ravandi, F; Church, SE; Vadakekolathu, J; Rutella, S; Sun, J; Yang, K; Baughman, J; Curtis, T; Timmeny, E; Cali, K; Tran, K; Muth, J; La Motte-Mohs, R; Poirot, C; Pallis, A; Cesano, A; Bonvini, E; Wigginton, J; Lowenberg, B; Davidson-Moncada, JK; DiPersio, JF

Published Date

  • November 29, 2018

Published In

Volume / Issue

  • 132 /

Published By


  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood-2018-99-117085

Conference Name

  • 60th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference Location

  • San Diego, CA

Conference Start Date

  • December 1, 2018

Conference End Date

  • December 4, 2018